Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3105)
All Articles published online
|
Oct 21, 2006 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao P, Mao X, Talbot IC. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence. World J Gastroenterol 2006; 12(39): 6391-6396 [PMID: 17072968 DOI: 10.3748/wjg.v12.i39.6391] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i39/6391.htm |
| Number | Citing Articles |
| 1 |
D M Heijink, R S N Fehrmann, E G E de Vries, J J Koornstra, D Oosterhuis, A G J van der Zee, J H Kleibeuker, S de Jong. A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer. Oncogene 2011; 30(17): 2026 doi: 10.1038/onc.2010.578
|
| 2 |
Nara Yoon, Gun Yoon, Cheol Keun Park, Hyun-Soo Kim. Stromal p16 expression is significantly increased in malignant ovarian neoplasms. Oncotarget 2016; 7(40): 64665 doi: 10.18632/oncotarget.11660
|
| 3 |
Mary P. Gillam, Cheol Ryong Ku, Yang Jong Lee, Jean Kim, Se Hoon Kim, Sue Ji Lee, Byungjin Hwang, JaeHyung Koo, Rhonda D. Kineman, Hiroaki Kiyokawa, Eun Jig Lee. Somatotroph-Specific Aip-Deficient Mice Display Pretumorigenic Alterations in Cell-Cycle Signaling. Journal of the Endocrine Society 2017; 1(2): 78 doi: 10.1210/js.2016-1004
|
| 4 |
C Romagosa, S Simonetti, L López-Vicente, A Mazo, M E Lleonart, J Castellvi, S Ramon y Cajal. p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene 2011; 30(18): 2087 doi: 10.1038/onc.2010.614
|
| 5 |
Xue Ying Shi, Brahm Bhagwandeen, Anthony S-Y. Leong. p16, Cyclin D1, Ki-67, and AMACR as Markers for Dysplasia in Barrett Esophagus. Applied Immunohistochemistry & Molecular Morphology 2008; 16(5): 447 doi: 10.1097/PAI.0b013e318168598b
|
| 6 |
Sonia I. Vlaicu, Cosmin A. Tegla, Cornelia D. Cudrici, Matthew Fosbrink, Vingh Nguyen, Philippe Azimzadeh, Violeta Rus, Hegang Chen, Petru A. Mircea, Abulkalam Shamsuddin, Horea Rus. Epigenetic modifications induced by RGC-32 in colon cancer. Experimental and Molecular Pathology 2010; 88(1): 67 doi: 10.1016/j.yexmp.2009.10.010
|
| 7 |
Yui Terayama, Tetsuro Matsuura, Kiyokazu Ozaki, Javier S Castresana. Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation. PLOS ONE 2016; 11(7): e0159090 doi: 10.1371/journal.pone.0159090
|
| 8 |
Abhijnya Vijayavittal Kanugovi, Chitra Joseph, Satish Siripini, Khanderao Paithankar, Sreedhar Subbarao Amere. Compromising the constitutive p16INK4a expression sensitizes human neuroblastoma cells to Hsp90 inhibition and promotes premature senescence. Journal of Cellular Biochemistry 2020; 121(4): 2770 doi: 10.1002/jcb.29493
|
| 9 |
Tomoko Goto, Masashi Takano, Junko Hirata, Toshiyuki Kohno, Shigenori Ohtsuka, Keiichi Fujiwara, Hitoshi Tsuda. p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer. International Journal of Cancer 2009; 125(2): 339 doi: 10.1002/ijc.24315
|
| 10 |
Abdulmohsen Alhejaily, Andrew G. Day, Harriet E. Feilotter, Tara Baetz, David P. LeBrun. Inactivation of the CDKN2A Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome. Clinical Cancer Research 2014; 20(6): 1676 doi: 10.1158/1078-0432.CCR-13-2175
|
| 11 |
Daniela D’Arcangelo, Lavinia Tinaburri, Elena Dellambra. The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer. International Journal of Molecular Sciences 2017; 18(7): 1591 doi: 10.3390/ijms18071591
|
| 12 |
Huan Zhao, Xuan Zhang, Zhifeng Han, Yanjun Wang. Circulating anti‐p16a IgG autoantibodies as a potential prognostic biomarker for non‐small cell lung cancer. FEBS Open Bio 2018; 8(11): 1875 doi: 10.1002/2211-5463.12535
|
| 13 |
Pablo Conesa-Zamora, Asunción Doménech-Peris, Francisco J. Orantes-Casado, Sebastián Ortiz-Reina, Laura Sahuquillo-Frías, Jesús Acosta-Ortega, José García-Solano, Miguel Pérez-Guillermo. Effect of Human Papillomavirus on Cell Cycle–Related Proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in Precursor Lesions of Cervical Carcinoma. American Journal of Clinical Pathology 2009; 132(3): 378 doi: 10.1309/AJCPO0WY1VIFCYDC
|
| 14 |
Amriti R. Lulla, Michael J. Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El-Deiry. miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells. Cancer Research 2017; 77(24): 6902 doi: 10.1158/0008-5472.CAN-17-1767
|
| 15 |
Dalibor V. Jovanovic, Slobodanka L. Mitrovic, Milos Z. Milosavljevic, Milena B. Ilic, Vesna D. Stankovic, Milena S. Vuletic, Milica N. Dimitrijevic Stojanovic, Danijela B. Milosev, Goran L. Azanjac, Vladica M. Nedeljkovic, Dragce Radovanovic. Breast Cancer and p16: Role in Proliferation, Malignant Transformation and Progression. Healthcare 2021; 9(9): 1240 doi: 10.3390/healthcare9091240
|
| 16 |
Roberto Gallus, Davide Rizzo, Giorgia Rossi, Luca Mureddu, Jacopo Galli, Alberto Artuso, Francesco Bussu. p16 Expression in Laryngeal Squamous Cell Carcinoma: A Surrogate or Independent Prognostic Marker?. Pathogens 2024; 13(2): 100 doi: 10.3390/pathogens13020100
|
| 17 |
Yue Liu, Xiufeng Zhong, Shangtao Wan, Wenxin Zhang, Jianxian Lin, Ping Zhang, Yongping Li. p16INK4a expression in retinoblastoma: a marker of differentiation grade. Diagnostic Pathology 2014; 9(1) doi: 10.1186/s13000-014-0180-1
|
| 18 |
Alfred King-Yin Lam, Kate Ong, Mahmound Jafari Giv, Yik-Hong Ho. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008; 40(6): 580 doi: 10.1080/00313020802320713
|
| 19 |
Mutsuko Omatsu, Toshiaki Kunimura, Tetsuya Mikogami, Akira Shiokawa, Atsuko Masunaga, Tomoko Nagai, Akihiko Kitami, Takashi Suzuki, Mitsutaka Kadokura. Cyclin-dependent kinase inhibitors, p16 and p27, demonstrate different expression patterns in thymoma and thymic carcinoma. General Thoracic and Cardiovascular Surgery 2014; 62(11): 678 doi: 10.1007/s11748-014-0437-3
|
| 20 |
Gun Yoon, Chang Won Koh, Nara Yoon, Ji-Ye Kim, Hyun-Soo Kim. Stromal p16 expression is significantly increased in endometrial carcinoma. Oncotarget 2017; 8(3): 4826 doi: 10.18632/oncotarget.13594
|
| 21 |
Emily A. O’Sullivan, Ryan Wallis, Federica Mossa, Cleo L. Bishop. The paradox of senescent-marker positive cancer cells: challenges and opportunities. npj Aging 2024; 10(1) doi: 10.1038/s41514-024-00168-y
|
| 22 |
Ghada Hosny, Omar A Ahmed, Rania Makboul Ahmed, Sabah Ahmed Fadel. Expression of p16 Tumor Suppressor Protein in Malignant Ovarian Germ Cell Tumors; Immunohistochemical Study. International Journal of Surgical Pathology 2024; 32(1): 66 doi: 10.1177/10668969231168358
|
| 23 |
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Damak, Lobna Ayadi, Abdelmajid Khabir, Ali Amouri, Foued Frikha, Sameh Ellouz, Mounir Frikha, Tahia Sellami-Boudawara, Raja Mokdad-Gargouri. Expression of p16INK4a, Alone or Combined With p53, is Predictive of Better Prognosis in Colorectal Adenocarcinoma in Tunisian Patients. Applied Immunohistochemistry & Molecular Morphology 2011; 19(6): 562 doi: 10.1097/PAI.0b013e3182143380
|